Clinical Trial Update: Ertugliflozin for Functional Mitral Regurgitation [Phase 3]

View source ↗

Summary

Phase 3 trial of ertugliflozin for functional mitral regurgitation in patients with left ventricular systolic dysfunction has completed with results posted on J…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Mitral Regurgitation

Drugs mentioned

• Ertugliflozin (ertugliflozin)

Snippet

Sponsor: Asan Medical Center | Conditions: Mitral Valve Insufficiency, Left Ventricular Systolic Dysfunction | Phase 3 | Status: COMPLETED | Results posted: 2025-01-06